Skip to main content
Premium Trial:

Request an Annual Quote

Cytogen's AxCell Unit in Partnership with InforMax


PRINCETON, NJ--AxCell Biosciences, the wholly owned subsidiary of Cytogen, signed a letter of intent with InforMax to market AxCell's proteomics database as part of an enterprise bioinformatics solution to pharmaceutical, biotechnology, and agricultural industries. The multi-year agreement provides for technology development by InforMax to link AxCell's database to InforMax's a molecular biology and genetics product, Software Solution for Bio-Medicine. AxCell's proprietary technology identifies protein-protein interactions to create its Inter-Functional Proteomic database. Through their collaboration, the two companies said they would link the database with an intuitive user interface in an enterprise system design to allow customers to utilize the information with other existing data and algorithms.

Filed under

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.